ArticleWorld journal of urology2026
In vitro performance of the Vortex Intelligent Stone Optimized Removal (VISOR) system versus the flexible and navigable suction ureteral access sheath (FANS) on stone clearance efficiency and intrarenal pressure control.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionFlexible and navigable suction ureteral access sheath (FANS) ureteroscopy has been recognized as an important development in the suction era of endourology. The Vortex Intelligent Stone Optimized Removal (VISOR) system has recently been introduced as an alternative to FANS, featuring an integrated irrigation-suction dual-channel and IRP control design. This study aimed to evaluate the efficacy of VISOR system in comparison with FANS in vitro.
methods3D-printed renal models were used, and 3 g of human calcium phosphate stones were treated via VISOR system versus FANS ureteroscopy. All procedures were performed by a single experienced urologist with a holmium laser. Primary outcome was stone clearance efficiency (SCE), calculated as: SCE (%) = [(Initial stone mass - Residual stone mass) / Initial stone mass] × 100%. Secondary outcomes included operative time, total laser energy use, residual stone mass and total stone mass removed. Accuracy of IRP measurements was also tested for the VISOR system.
resultsThe VISOR system demonstrated comparable SCE to FANS (95.1 ± 0.6% vs. 94.8 ± 0.7%, p = 0.78). The mean operative time in the VISOR group was significantly lower by 26.2% compared with FANS (55.1 ± 2.2 vs. 74.7 ± 2.3 min, p = 0.003). We found no difference in total laser energy use (33.6 ± 1.4 vs. 33.3 ± 5.3 kJ, p = 0.96), residual stone mass (0.15 ± 0.03 vs. 0.15 ± 0.04 g, p = 0.99) and total removed stone mass (1.86 ± 0.13 vs. 1.81 ± 0.12 g, p = 0.79). The VISOR system's pressure sensor showed good correlation with an external reference pressure meter (Spearman R = 0.99, p < 0.0001).
conclusionsBased on these in vitro findings, the VISOR integrated dual-channel system demonstrated SCE comparable to FANS, with significantly shorter operative time and reliable real-time IRP control. These results suggest that the VISOR system represents a promising candidate for further clinical evaluation; whether these performance advantages translate to improved patient outcomes in vivo requires confirmation in prospective clinical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.